Results 121 to 130 of about 216,439 (378)

Outcome of Chronic Myeloid Leukemia Patients Not in Deep Molecular Response: Results From the GIMEMA LabNet CML Network Database. [PDF]

Am J Hematol
American Journal of Hematology, Volume 100, Issue 8, Page 1467-1470, August 2025.
Stagno F, Cucci R, Marsili G, Castagnetti F, Galimberti S, Izzo B, Sorà F, Soverini S, Messina M, Piciocchi A, Bonifacio M, Cilloni D, Iurlo A, Martinelli G, Rosti G, Fazi P, Vignetti M, Breccia M, Allegra A, Pane F.   +19 more
europepmc   +2 more sources

Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.

Blood, 2015
We studied the influence of comorbidities on remission rate and overall survival (OS) in patients with chronic myeloid leukemia (CML). Participants of the CML Study IV, a randomized 5-arm trial designed to optimize imatinib therapy, were analyzed for ...
S. Saussele, Marie-Paloma Krauss, R. Hehlmann, M. Lauseker, U. Proetel, Lida Kalmanti, B. Hanfstein, A. Fabarius, D. Kraemer, W. Berdel, M. Bentz, P. Staib, M. de Wit, M. Wernli, F. Zettl, H. Hebart, M. Hahn, J. Heymanns, I. Schmidt-Wolf, N. Schmitz, M. Eckart, W. Gassmann, A. Bartholomäus, A. Pezzutto, E. O. Leibundgut, D. Heim, S. Krause, A. Burchert, W. Hofmann, J. Hasford, A. Hochhaus, M. Pfirrmann, Martin C. Müller   +32 more
semanticscholar   +1 more source

BRE‐X Emissions Database for End‐of‐Life Scenarios of Selective Building Construction Materials to Enable Circular Economy in Construction

Journal of Advanced Manufacturing and Processing, EarlyView.
ABSTRACT In the United States, construction and demolition debris predominately end up in landfills with minimal end‐of‐life Re‐X (recover, recycle, reuse, etc.) scenarios, resulting in large environmental impacts and lost opportunities for material recovery.
Naveen Kumar Muthumanickam, Swaroop Atnoorkar, Heather Goetsch, Michael Deru, Jordan Palmeri, Milad Ashtiani, Vaclav Hasik, Mirko Farnetani   +7 more
wiley   +1 more source

Lawsonella clevelandensis as the causative agent of a breast abscess

IDCases, 2018
Lawsonella clevelandensis is a Gram-stain-positive, partially acid-fast, anaerobic, being considered a new species within a new genus in the suborder Corynebacterineae. There are only a few cases reported worldwide.
M. Favila Menezes, Maria José Sousa, P. Paixão, J. Atouguia, I. Negreiros, M.J. Simões   +5 more
doaj  

Comparison of Socal Score and Hasford Score Against the Response of Imatinib Mesylate Therapy in Patients with Chronic Granulocytic Leukemia in dr. Saiful Anwar Hospital Malang

Jurnal Penyakit Dalam Indonesia, 2019
Introduction. The Socal and Hasford scores developed before the era of tirosine kinase inhibitor (TKI) therapy to provide predictions and prognosis for the results of therapy for chronic myeloid leukemia patients (CML). Until now the superiority of Socal
Somarnam, Budi Darmawan Machsoos, Djoko Heri Hermanto   +2 more
doaj   +1 more source

CML/RAGE signal induces calcification cascade in diabetes

Diabetology & Metabolic Syndrome, 2016
ObjectiveVascular calcification is a significant predictor of coronary heart disease events, stroke, and lower-limb amputation. Advanced glycation end-products (AGEs) play a key role in the development of vascular calcification.
Zhongqun Wang, Lihua Li, Rui Du, Jinchuan Yan, Naifeng Liu, W. Yuan, Yicheng Jiang, Suining Xu, F. Ye, Guoyue Yuan, Baohai Zhang, Pei-jing Liu   +11 more
semanticscholar   +1 more source

Progress in Biomimetic Microdevices for Anticancer Drug Screening and their Potential for Enhancing In Vivo Efficacy

Advanced NanoBiomed Research, EarlyView.
Biomimetic microdevices are redefining anticancer drug screening by mimicking complex tumor microenvironments. This review highlights advances in microfluidic systems, cell microarrays, and in vivo‐like models, offering new insights into drug efficacy prediction and personalized medicine. The development of effective anticancer drugs remains a critical
Ching‐Te Kuo, Yen‐Tzu Liao, Hsinyu Lee   +2 more
wiley   +1 more source

Novel approaches to therapy in CML.

Hematology. American Society of Hematology. Education Program, 2017
Treatment with tyrosine kinase inhibitors (TKIs) results in remission and prolongation of survival in most chronic myeloid leukemia (CML) patients but fails to eliminate the leukemia stem cells (LSCs) responsible for disease development and propagation ...
R. Bhatia
semanticscholar   +1 more source

Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus. [PDF]

Cancer
Abstract Background Improved outcome has been reported in chronic myeloid leukemia (CML) patients treated with tyrosine kinase inhibitors (TKIs) in sponsored trials. Methods This is a multicenter prospective cohort study of consecutive patients with newly diagnosed chronic phase CML from 19 regions in Italy.
Giai V, Rosso T, Castagnetti F, Pregno P, Bonifacio M, Capodanno I, Tiribelli M, Stagno F, Caocci G, Gozzini A, Luciano L, Galimberti S, Bocchia M, Patriarca A, Lanzarone G, Martino B, Guella A, Scortechini AR, Fava C, Fozza C, Sica S, Di Renzo N, Musto P, Pastore D, Maggi A, Pizzuti M, Antonia Melillo LM, Carella AM, Tarantini G, Mele A, Calistri E, Coppi MR, Saccona F, Scalzulli E, Battaglio B, Iezza M, Bitetti C, Freilone R, Rosti G, Albano F, Pane F, Specchia G, Ciccone G, Saglio G, Breccia M.   +44 more
europepmc   +2 more sources

Synchronization in coupled map lattices as an interface depinning

, 2003
We study an SOS model whose dynamics is inspired by recent studies of the synchronization transition in coupled map lattices (CML). The synchronization of CML is thus related with a depinning of interface from a binding wall.
A.S. Pikovsky, A.S. Pikovsky, Adam Lipowski, D.A. Egolf, F. Ginelli, H. Chaté, H. Fujisaka, H. Hinrichsen, K. Sneppen, L. Baroni, M. Droz, M.A. Muñoz, M.A. Muñoz, Michel Droz, P. Grassberger, P. Grassberger, P. Marcq, S. Boccaletti, U. Alon, V. Ahlers, Y. Tu, Z. Olami   +21 more
core   +1 more source